- Home
- CAPR vs YALA Comparison
CAPR vs YALA Comparison
Compare CAPR & YALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPR
- YALA
- Stock Information
- Founded
- CAPR 2005
- YALA 2016
- Country
- CAPR United States
- YALA United Arab Emirates
- Employees
- CAPR N/A
- YALA N/A
- Industry
- CAPR Biotechnology: Biological Products (No Diagnostic Substances)
- YALA Computer Software: Programming Data Processing
- Sector
- CAPR Health Care
- YALA Technology
- Exchange
- CAPR Nasdaq
- YALA Nasdaq
- Market Cap
- CAPR 578.4M
- YALA 621.2M
- IPO Year
- CAPR N/A
- YALA 2020
- Fundamental
- Price
- CAPR $14.06
- YALA $4.01
- Analyst Decision
- CAPR Strong Buy
- YALA
- Analyst Count
- CAPR 7
- YALA 0
- Target Price
- CAPR $39.29
- YALA N/A
- AVG Volume (30 Days)
- CAPR 1.1M
- YALA 132.7K
- Earning Date
- CAPR 02-27-2025
- YALA 03-10-2025
- Dividend Yield
- CAPR N/A
- YALA N/A
- EPS Growth
- CAPR N/A
- YALA 31.83
- EPS
- CAPR N/A
- YALA 0.74
- Revenue
- CAPR $23,228,045.00
- YALA $329,773,319.00
- Revenue This Year
- CAPR N/A
- YALA $6.23
- Revenue Next Year
- CAPR $74.85
- YALA $11.04
- P/E Ratio
- CAPR N/A
- YALA $5.38
- Revenue Growth
- CAPR 65.33
- YALA 5.34
- 52 Week Low
- CAPR $3.52
- YALA $3.71
- 52 Week High
- CAPR $23.40
- YALA $5.54
- Technical
- Relative Strength Index (RSI)
- CAPR 48.54
- YALA 45.68
- Support Level
- CAPR $12.31
- YALA $3.87
- Resistance Level
- CAPR $16.17
- YALA $4.19
- Average True Range (ATR)
- CAPR 0.82
- YALA 0.09
- MACD
- CAPR 0.11
- YALA 0.00
- Stochastic Oscillator
- CAPR 45.34
- YALA 48.57
About CAPR Capricor Therapeutics Inc.
Capricor Therapeutics Inc is a biotechnology company focused on advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat and prevent a wide range of diseases with targeted delivery.
About YALA Yalla Group Limited each representing one
Yalla Group Ltd is a MENA-based online social networking and gaming company. It operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games popular in MENA, with in-game voice chat and localized majlis functions.